Similar articles

• Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.

  Gunji T, Kawauchi N, Akahane M, Watanabe K, Kanamori H, Ohnishi S. Gunji T, et al. Int J Oncol. 2002 Aug;21(2):427-32. Int J Oncol. 2002. PMID: 12118341 Review.
• [Transcatheter arterial embolization/chemoembolization].

  Sakaguchi H, Uchida H, Tanaka T, Anai H, Yamamoto K, Kichikawa K, Ohishi H. Sakaguchi H, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:521-7. Nihon Rinsho. 2001. PMID: 11762005 Review. Japanese. No abstract available.
• [The value of using MRI in accessing the efficacy of transcatheter arterial chemoembolization in hepatocellular carcinoma].

  Wang LD, Yu CX, Qin M. Wang LD, et al. Zhonghua Gan Zang Bing Za Zhi. 2008 Nov;16(11):872-4. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 19032879 Review. Chinese. No abstract available.
• Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.

  Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H. Dohmen K, et al. Hepatogastroenterology. 2001 Sep-Oct;48(41):1409-15. Hepatogastroenterology. 2001. PMID: 11677976
• Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.

  Maeda S, Shibata J, Fujiyama S, Tanaka M, Noumaru S, Sato K, Tomita K. Maeda S, et al. Hepatogastroenterology. 2003 May-Jun;50(51):809-13. Hepatogastroenterology. 2003. PMID: 12828090